//
A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
Angiotensin–neprilysin inhibition versus enalapril in heart failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories